Using the COVID-19 IgM/IgA ELISA (Vircell, S.L.)kit, widely implemented in Spanish hospitals, a high number of false positives and lower seroprevalences compared with the Luminex estimates were found, indicating a significantly lower specificity and sensitivity. The gene discussed is CD79A; the disease is COVID-19.